![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 49829](svg/group-56.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 49831](svg/group-57.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51209](svg/group-cbrn-1.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 49833](svg/group-58.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 49835](svg/group-59.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51211](svg/group-space-big-science-1.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51200](svg/group-optronics.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51204](svg/group-optomechanical.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51202](svg/group-photonics.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51212](svg/group-application-center.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51214](svg/group-distributor-map.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51216](svg/group-register-1.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51218](svg/group-media.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 51220](svg/group-faq.svg)
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 69984](png/about-us-2.png){kind=small}
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 69981](png/governance.png){kind=small}
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 69990](png/business-units.png){kind=small}
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 69987](png/subsidiaries.png){kind=small}
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 69997](png/location.png){kind=small}
![[PUBLICATION PRECELLYS] Icariin ameliorates estrogen-deficiency induced bone loss by enhancing IGF-I signaling via its crosstalk with non-genomic ERa signaling Bertin Technologies 70000](png/certifications.png){kind=small}
Abstract
Background
Rapid, non-genomic estrogen receptor (ER) signaling plays an integral role in mediating the tissue selective properties of ER modulators. Icariin, a bone bioactive flavonoid, has been reported to selectively activate non-genomic ERa signaling in in vitro and in vivo studies.
Purpose
The mechanisms underlying the estrogen-like bone protective effects of icariin are not fully understood, especially those that are related to insulin-like growth factor I (IGF-1) signaling. The bone protective effects of icariin were investigated in female mature ovariectomized (OVX) rats and the signaling of IGF-IR- ERa cross-talk was determined in osteoblastic cells.
Sample type
Rat bone samples
Target
RNA Extraction
